PET Chemistry: The Driving Force in Molecular Imaging describes the development of radiochemicals as concepts move from bench work to clinical products. Molecular targets have been applied as tools for personalized medicine in the areas of disease imaging, therapy assessment, selection of patients
No takes yet. Share an insight, caveat, or question.
Schubiger et al. (2007) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: